≡ Risteys
R14

Documentation Changelog GitHub Contact & Feedback

Congenital malformations of lung

DOID EFO Endpoint Browser PheWeb

Q17_CONGEN_MALFO_LUNG

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps

FinnGen

Phenotype data

519870

1. Apply sex-specific rule

None

519870

2. Check conditions

None

519870

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — Q33
  • Cause of death: ICD-10 — Q33

2 out of 7 registries used, show all original rules.

96

4. Check minimum number of events

None

96

5. Include endpoints

None

96

6. Filter based on genotype QC (FinnGen only)

90

Control definitions (FinnGen only)

Control exclude
Q17_CONGEN_MALFO_RESPI_SYSTEM

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF4
Parent code in ICD-10
Q3[0-4]
Name in latin
Malformationes congenitae pulmonis/pulmonum

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 981 473 506
Only index persons 577 282 295
Unadjusted period prevalence (%)
Whole population 0.01 0.01 0.01
Only index persons 0.01 0.01 0.01
Median age at first event (years)
Whole population 4.16 6.77 1.64
Only index persons 29.63 36.04 23.51

-FinnGen-

Key figures

All Female Male
Number of individuals 90 48 42
Unadjusted period prevalence (%) 0.02 0.02 0.02
Median age at first event (years) 43.04 45.70 40.01

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
96
Matched controls
960
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
13.7
30.2
34
37
Q33.2
ICD-10 Finland
Sequestration of lung
+∞
29.7
27
*
Q33.08
ICD-10 Finland
Congenital cystic lung
+∞
22.8
21
*
Q33.6
ICD-10 Finland
Hypoplasia and dysplasia of lung
+∞
12.8
12
*
UGC12
NOMESCO Finland
Flexible bronchoscopy
12.0
12.0
22
23
J18.9
ICD-10 Finland
Pneumonia, unspecified
4.5
11.1
38
122
Q33.9
ICD-10 Finland
Congenital malformation of lung, unspecified
+∞
9.5
9
*
Q33.00
ICD-10 Finland
Solitary congenital cyst in the lungs
+∞
9.5
9
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
3.5
8.5
56
272
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
4.2
8.4
27
81
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
8.5
7.6
16
22
GDC00
NOMESCO Finland
Lobectomy of lung
86.5
7.5
8
*
Q33.4
ICD-10 Finland
Congenital bronchiectasis
+∞
7.4
7
*
Q33.80
ICD-10 Finland
Congenital [cystic] adenomatoid malformation of lung
+∞
7.4
7
*
R03AC02
ATC
salbutamol; inhalant
3.4
7.0
69
411
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
6.4
6.7
17
31
UGC02
NOMESCO Finland
Rigid bronchoscopy
28.8
6.3
8
*
Q34.1
ICD-10 Finland
Congenital cyst of mediastinum
+∞
6.3
6
*

TimeCodeWAS

↥

TODO / Current known limitations:

  • Only showing the top 300 codes, because showing all (sometimes 20k) makes the page too slow.
  • Legend / how to read the glyphs.
  • Show details (e.g. Fisher or Chi-square test, LR+, etc.) when clicking on a row.
  • Explanation on the underlying data / how the TimeCodeWAS is done (e.g. matched cases / controls, eligibility).
  • Download CSV.
  • No filters and sorters.
  • Limited amount of endpoints (~400) having TimeCodeWAS data.
  • Cross-links to Risteys lab test pages for lab test codes.
OMOP concept
ln(OR)
%cases with code / %controls with code
2×2 table
Outpatient Visit
OP [9202]
2.7e-01
9.4e-01
1.1e+00
4.8e+00
1.5e+00
1.4e+00
2.9e-01
cases:76.19%
controls:70.86%
cases:69.05%
controls:46.52%
cases:29.76%
controls:11.87%
cases:46.43%
controls:0.72%
cases:30.95%
controls:8.77%
cases:75.61%
controls:42.86%
cases:82.19%
controls:77.61%
64
591
20
243
58
388
26
446
25
99
59
735
39
6
45
828
26
73
58
759
62
351
20
468
60
572
13
165
Pulmonary Disease
29 [38004472]
6.8e-01
2.6e+00
—
1.0e+50
—
3.0e+00
1.6e+00
cases:9.52%
controls:5.04%
cases:27.38%
controls:2.76%
—
—
cases:50.00%
controls:0.00%
—
—
cases:36.59%
controls:2.81%
cases:28.77%
controls:7.73%
8
42
76
792
23
23
61
811
—
42
0
42
834
—
30
23
52
796
21
57
52
680
Inpatient Hospital
21 [8717]
-2.8e-02
1.1e+00
2.3e+00
—
1.8e+00
2.0e+00
-2.2e-01
cases:27.38%
controls:27.94%
cases:22.62%
controls:9.23%
cases:5.95%
controls:0.60%
—
—
cases:5.95%
controls:1.08%
cases:35.37%
controls:6.72%
cases:15.07%
controls:18.05%
23
233
61
601
19
77
65
757
5
5
79
829
—
5
9
79
823
29
55
53
764
11
133
62
604
Supplier / Service Provider
OMOP5117446 [33004]
-1.3e+00
-5.7e-01
—
—
—
2.9e+00
3.0e+00
cases:10.71%
controls:30.10%
cases:5.95%
controls:10.07%
—
—
—
—
—
—
cases:12.20%
controls:0.73%
cases:16.44%
controls:0.95%
9
251
75
583
5
84
79
750
—
—
—
10
6
72
813
12
7
61
730
Nonallergic asthma
J45.1 [45557625]
—
—
—
—
—
2.4e+00
2.0e+00
—
—
—
—
—
—
—
—
—
—
cases:7.32%
controls:0.73%
cases:9.59%
controls:1.36%
—
—
—
—
—
6
6
76
813
7
10
66
727
INR in Blood by Coagulation assay
34714-6 [3032080]
5.3e-01
1.2e+00
2.3e+00
—
-1.0e+50
1.9e+00
-1.8e-01
cases:7.14%
controls:4.32%
cases:9.52%
controls:3.00%
cases:5.95%
controls:0.60%
—
—
cases:0.00%
controls:0.60%
cases:14.63%
controls:2.44%
cases:9.59%
controls:11.26%
6
36
78
798
8
25
76
809
5
5
79
829
—
0
5
84
827
12
20
70
799
7
83
66
654
12 lead EKG panel
34534-8 [3044889]
4.7e-01
1.1e+00
2.5e+00
—
—
1.5e+00
1.1e-01
cases:17.86%
controls:11.99%
cases:13.10%
controls:4.92%
cases:7.14%
controls:0.60%
—
—
—
—
cases:18.29%
controls:4.76%
cases:23.29%
controls:21.30%
15
100
69
734
11
41
73
793
6
5
78
829
—
—
15
39
67
780
17
157
56
580
C reactive protein [Mass/volume] in Serum or Plasma
1988-5 [3020460]
2.5e-01
8.0e-01
2.3e+00
—
1.6e+00
8.6e-01
2.5e-01
cases:30.95%
controls:25.90%
cases:28.57%
controls:15.23%
cases:20.24%
controls:2.40%
—
—
cases:13.10%
controls:2.88%
cases:30.49%
controls:15.63%
cases:43.84%
controls:37.86%
26
216
58
618
24
127
60
707
17
20
67
814
—
11
24
73
808
25
128
57
691
32
279
41
458
Thorax X-ray examination
GD1AA [2001303617]
5.0e-01
1.5e+00
—
1.0e+50
—
2.2e+00
1.0e+00
cases:9.52%
controls:6.00%
cases:10.71%
controls:2.52%
—
—
cases:11.90%
controls:0.00%
—
—
cases:19.51%
controls:2.69%
cases:17.81%
controls:7.19%
8
50
76
784
9
21
75
813
—
10
0
74
834
—
16
22
66
797
13
53
60
684
CBC panel - Blood by Automated count
58410-2 [40761511]
2.3e-01
9.9e-01
1.8e+00
—
1.2e+00
9.5e-01
-1.1e-01
cases:34.52%
controls:29.62%
cases:33.33%
controls:15.71%
cases:17.86%
controls:3.60%
—
—
cases:9.52%
controls:3.13%
cases:34.15%
controls:16.73%
cases:41.10%
controls:43.69%
29
247
55
587
28
131
56
703
15
30
69
804
—
8
26
76
806
28
137
54
682
30
322
43
415
Emergency Medicine
93 [38004510]
5.8e-01
1.2e+00
2.2e+00
—
—
7.2e-01
-1.8e-01
cases:19.05%
controls:11.63%
cases:16.67%
controls:5.88%
cases:7.14%
controls:0.84%
—
—
—
—
cases:12.20%
controls:6.35%
cases:19.18%
controls:22.12%
16
97
68
737
14
49
70
785
6
7
78
827
—
—
10
52
72
767
14
163
59
574
Case Management Agency
251B00000X [38004193]
-3.2e-03
1.8e-01
4.2e-01
3.2e+00
3.0e-01
2.6e-01
4.6e-02
cases:60.71%
controls:60.79%
cases:59.52%
controls:55.16%
cases:28.57%
controls:20.86%
cases:30.95%
controls:1.80%
cases:29.76%
controls:23.92%
cases:65.85%
controls:59.83%
cases:79.45%
controls:78.70%
51
507
33
327
50
460
34
374
24
174
60
660
26
15
58
819
25
199
59
633
54
490
28
329
58
580
15
157
Pneumonia, unspecified
J18.9 [45601123]
1.9e+00
—
—
—
1.0e+50
2.7e+00
—
cases:7.14%
controls:1.08%
—
—
—
—
—
—
cases:5.95%
controls:0.00%
cases:9.76%
controls:0.73%
—
—
6
9
78
825
—
—
—
5
0
79
832
8
6
74
813
—
Thoracic and Cardiac Surgery
OMOP4822009 [45756830]
—
—
—
1.0e+50
1.0e+50
1.0e+50
2.6e+00
—
—
—
—
—
—
cases:13.10%
controls:0.00%
cases:9.52%
controls:0.00%
cases:24.39%
controls:0.00%
cases:8.22%
controls:0.68%
—
—
—
11
0
73
834
8
0
76
832
20
0
62
819
6
5
67
732
Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method
4537-7 [3013707]
-4.7e-02
8.6e-01
2.5e+00
—
—
4.3e-01
2.5e-01
cases:14.29%
controls:14.87%
cases:16.67%
controls:7.79%
cases:8.33%
controls:0.72%
—
—
—
—
cases:10.98%
controls:7.45%
cases:26.03%
controls:21.57%
12
124
72
710
14
65
70
769
7
6
77
828
—
—
9
61
73
758
19
159
54
578
Sodium [Moles/volume] in Serum or Plasma
2951-2 [3019550]
2.6e-01
5.3e-01
1.6e+00
—
1.4e+00
8.9e-01
8.9e-02
cases:30.95%
controls:25.66%
cases:26.19%
controls:17.27%
cases:13.10%
controls:2.88%
—
—
cases:10.71%
controls:2.76%
cases:34.15%
controls:17.58%
cases:43.84%
controls:41.66%
26
214
58
620
22
144
62
690
11
24
73
810
—
9
23
75
809
28
144
54
675
32
307
41
430
Potassium [Moles/volume] in Serum or Plasma
2823-3 [3023103]
2.3e-01
5.1e-01
1.6e+00
—
1.4e+00
9.0e-01
7.8e-02
cases:30.95%
controls:26.26%
cases:26.19%
controls:17.63%
cases:13.10%
controls:3.00%
—
—
cases:10.71%
controls:2.76%
cases:34.15%
controls:17.46%
cases:43.84%
controls:41.93%
26
219
58
615
22
147
62
687
11
25
73
809
—
9
23
75
809
28
143
54
676
32
309
41
428
Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
6768-6 [3035995]
-1.8e-01
8.1e-01
2.4e+00
—
—
5.3e-01
-3.7e-01
cases:13.10%
controls:15.35%
cases:16.67%
controls:8.15%
cases:10.71%
controls:1.08%
—
—
—
—
cases:14.63%
controls:9.16%
cases:19.18%
controls:25.51%
11
128
73
706
14
68
70
766
9
9
75
825
—
—
12
75
70
744
14
188
59
549
Asthma, unspecified
J45.9 [45562456]
—
1.6e+00
—
—
—
2.4e+00
8.2e-01
—
—
cases:5.95%
controls:1.20%
—
—
—
—
—
—
cases:9.76%
controls:0.98%
cases:9.59%
controls:4.48%
—
5
10
79
824
—
—
—
8
8
74
811
7
33
66
704
Ingrowing nail
L60.0 [45548199]
—
—
—
—
—
—
2.4e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:6.85%
controls:0.68%
—
—
—
—
—
—
5
5
68
732
Base excess in Arterial blood by calculation
1925-7 [3003396]
-1.0e+50
—
—
—
—
2.4e+00
—
cases:0.00%
controls:0.84%
—
—
—
—
—
—
—
—
cases:6.10%
controls:0.61%
—
—
0
7
84
827
—
—
—
—
5
5
77
814
—
Carbon dioxide [Partial pressure] in Arterial blood
2019-8 [3027946]
-1.0e+50
—
—
—
—
2.4e+00
—
cases:0.00%
controls:0.84%
—
—
—
—
—
—
—
—
cases:6.10%
controls:0.61%
—
—
0
7
84
827
—
—
—
—
5
5
77
814
—
Oxygen [Partial pressure] in Arterial blood
2703-7 [3027801]
-1.0e+50
—
—
—
—
2.4e+00
—
cases:0.00%
controls:0.84%
—
—
—
—
—
—
—
—
cases:6.10%
controls:0.61%
—
—
0
7
84
827
—
—
—
—
5
5
77
814
—
pH of Arterial blood
2744-1 [3019977]
-1.0e+50
—
—
—
—
2.4e+00
—
cases:0.00%
controls:0.84%
—
—
—
—
—
—
—
—
cases:6.10%
controls:0.61%
—
—
0
7
84
827
—
—
—
—
5
5
77
814
—
Pharmacy visit
OMOP4822462 [581458]
2.3e-01
1.5e+00
1.4e-01
1.8e+00
7.7e-01
6.7e-01
-9.2e-02
cases:96.43%
controls:95.56%
cases:94.05%
controls:77.58%
cases:40.48%
controls:37.17%
cases:7.14%
controls:1.20%
cases:54.76%
controls:35.82%
cases:87.80%
controls:78.63%
cases:94.52%
controls:94.98%
81
797
3
37
79
647
5
187
34
310
50
524
6
10
78
824
46
298
38
534
72
644
10
175
69
700
4
37
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
R5110 [2001310246]
—
—
—
—
—
—
2.2e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:8.22%
controls:0.95%
—
—
—
—
—
—
6
7
67
730
salbutamol; inhalant
R03AC02 [21603256]
8.9e-01
1.1e+00
—
—
—
6.6e-01
1.0e+00
cases:27.38%
controls:13.43%
cases:19.05%
controls:6.95%
—
—
—
—
—
—
cases:13.41%
controls:7.45%
cases:35.62%
controls:16.42%
23
112
61
722
16
58
68
776
—
—
—
11
61
71
758
26
121
47
616
Neutrophils [#/volume] in Blood by Automated count
751-8 [3013650]
1.0e-01
4.9e-01
2.1e+00
—
—
1.3e-01
8.8e-02
cases:14.29%
controls:13.07%
cases:10.71%
controls:6.83%
cases:8.33%
controls:1.08%
—
—
—
—
cases:8.54%
controls:7.57%
cases:17.81%
controls:16.55%
12
109
72
725
9
57
75
777
7
9
77
825
—
—
7
62
75
757
13
122
60
615
Pediatric Surgery
OMOP4822020 [45756819]
1.4e+00
—
—
—
—
2.1e+00
—
cases:9.52%
controls:2.64%
—
—
—
—
—
—
—
—
cases:7.32%
controls:0.98%
—
—
8
22
76
812
—
—
—
—
6
8
76
811
—
Bacteria identified in Blood by Culture
600-7 [3023368]
1.3e+00
1.8e+00
—
—
—
2.1e+00
—
cases:9.52%
controls:2.88%
cases:7.14%
controls:1.20%
—
—
—
—
—
—
cases:7.32%
controls:0.98%
—
—
8
24
76
810
6
10
78
824
—
—
—
6
8
76
811
—
Bacteria identified in Urine by Culture
630-4 [3026008]
4.9e-01
—
—
—
—
2.1e+00
9.3e-01
cases:5.95%
controls:3.72%
—
—
—
—
—
—
—
—
cases:7.32%
controls:0.98%
cases:8.22%
controls:3.39%
5
31
79
803
—
—
—
—
6
8
76
811
6
25
67
712
Blood type and Crossmatch panel - Blood
34531-4 [3044640]
5.6e-01
—
—
—
—
2.1e+00
—
cases:8.33%
controls:4.92%
—
—
—
—
—
—
—
—
cases:9.76%
controls:1.34%
—
—
7
41
77
793
—
—
—
—
8
11
74
808
—
Outpatient Hospital
22 [8756]
-4.5e-01
1.0e+00
—
—
2.3e+00
2.0e+00
-1.6e-01
cases:16.67%
controls:23.86%
cases:16.67%
controls:6.71%
—
—
—
—
cases:5.95%
controls:0.60%
cases:29.27%
controls:5.13%
cases:12.33%
controls:14.11%
14
199
70
635
14
56
70
778
—
—
5
5
79
827
24
42
58
777
9
104
64
633
Blood group antibody screen [Presence] in Serum or Plasma
890-4 [3001079]
2.4e-01
7.2e-01
—
—
—
1.9e+00
—
cases:9.52%
controls:7.67%
cases:5.95%
controls:3.00%
—
—
—
—
—
—
cases:13.41%
controls:2.20%
—
—
8
64
76
770
5
25
79
809
—
—
—
11
18
71
801
—
ABO and Rh group [Type] in Blood
882-1 [3003694]
—
—
—
—
—
1.9e+00
—
—
—
—
—
—
—
—
—
—
—
cases:8.54%
controls:1.34%
—
—
—
—
—
—
—
7
11
75
808
—
Troponin T.cardiac [Mass/volume] in Serum or Plasma
6598-7 [3019800]
4.2e-01
1.9e+00
—
—
—
—
-3.6e-02
cases:7.14%
controls:4.80%
cases:8.33%
controls:1.32%
—
—
—
—
—
—
—
—
cases:9.59%
controls:9.91%
6
40
78
794
7
11
77
823
—
—
—
—
7
73
66
664
Atrial fibrillation and flutter
I48 [45596206]
—
—
—
—
—
—
1.9e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:12.33%
controls:2.04%
—
—
—
—
—
—
9
15
64
722
salmeterol and fluticasone
R03AK06 [21603280]
1.6e+00
2.2e+00
—
—
—
2.0e+00
1.9e+00
cases:5.95%
controls:1.32%
cases:5.95%
controls:0.72%
—
—
—
—
—
—
cases:6.10%
controls:0.85%
cases:9.59%
controls:1.63%
5
11
79
823
5
6
79
828
—
—
—
5
7
77
812
7
12
66
725
Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M
62238-1 [40764999]
9.2e-02
6.6e-01
1.8e+00
—
1.2e+00
4.7e-01
2.0e-02
cases:17.86%
controls:16.55%
cases:20.24%
controls:11.63%
cases:10.71%
controls:1.92%
—
—
cases:7.14%
controls:2.28%
cases:19.51%
controls:13.19%
cases:32.88%
controls:32.43%
15
138
69
696
17
97
67
737
9
16
75
818
—
6
19
78
813
16
108
66
711
24
239
49
498
Inpatient Visit
IP [9201]
4.0e-01
—
—
—
—
1.8e+00
—
cases:5.95%
controls:4.08%
—
—
—
—
—
—
—
—
cases:9.76%
controls:1.83%
—
—
5
34
79
800
—
—
—
—
8
15
74
804
—
Creatinine [Moles/volume] in Serum or Plasma
14682-9 [3020564]
1.2e-01
6.6e-01
1.7e+00
—
1.3e+00
7.9e-01
-8.9e-03
cases:32.14%
controls:29.50%
cases:33.33%
controls:20.50%
cases:19.05%
controls:4.08%
—
—
cases:11.90%
controls:3.61%
cases:39.02%
controls:22.59%
cases:47.95%
controls:48.17%
27
246
57
588
28
171
56
663
16
34
68
800
—
10
30
74
802
32
185
50
634
35
355
38
382
Leukocytes [#/volume] in Blood
26464-8 [3010813]
8.2e-02
7.0e-01
1.6e+00
—
9.8e-01
6.3e-01
-6.2e-02
cases:36.90%
controls:35.01%
cases:40.48%
controls:25.30%
cases:23.81%
controls:5.76%
—
—
cases:14.29%
controls:5.89%
cases:41.46%
controls:27.35%
cases:53.42%
controls:54.95%
31
292
53
542
34
211
50
623
20
48
64
786
—
12
49
72
783
34
224
48
595
39
405
34
332
amoxicillin; oral, parenteral
J01CA04 [21602823]
5.9e-01
1.6e+00
—
—
—
8.3e-01
4.0e-01
cases:35.71%
controls:23.62%
cases:26.19%
controls:6.83%
—
—
—
—
—
—
cases:15.85%
controls:7.57%
cases:27.40%
controls:20.22%
30
197
54
637
22
57
62
777
—
—
—
13
62
69
757
20
149
53
588
Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1742-6 [3006923]
-1.3e-01
3.2e-01
1.6e+00
—
—
4.0e-01
-1.8e-01
cases:25.00%
controls:27.58%
cases:25.00%
controls:19.42%
cases:11.90%
controls:2.76%
—
—
—
—
cases:26.83%
controls:19.66%
cases:41.10%
controls:45.59%
21
230
63
604
21
162
63
672
10
23
74
811
—
—
22
161
60
658
30
336
43
401
Hematocrit [Volume Fraction] of Blood by calculation
20570-8 [3009542]
8.2e-02
6.9e-01
1.5e+00
—
9.6e-01
6.3e-01
-5.6e-02
cases:36.90%
controls:35.01%
cases:40.48%
controls:25.42%
cases:22.62%
controls:5.88%
—
—
cases:14.29%
controls:6.01%
cases:41.46%
controls:27.35%
cases:53.42%
controls:54.82%
31
292
53
542
34
212
50
622
19
49
65
785
—
12
50
72
782
34
224
48
595
39
404
34
333
Erythrocytes [#/volume] in Blood
26453-1 [3026361]
8.2e-02
6.9e-01
1.5e+00
—
9.8e-01
6.8e-01
-9.0e-04
cases:36.90%
controls:35.01%
cases:40.48%
controls:25.42%
cases:22.62%
controls:5.88%
—
—
cases:14.29%
controls:5.89%
cases:42.68%
controls:27.35%
cases:54.79%
controls:54.82%
31
292
53
542
34
212
50
622
19
49
65
785
—
12
49
72
783
35
224
47
595
40
404
33
333
MCH [Entitic mass]
28539-5 [3035941]
8.2e-02
6.4e-01
1.5e+00
—
9.8e-01
6.3e-01
-5.6e-02
cases:36.90%
controls:35.01%
cases:39.29%
controls:25.42%
cases:22.62%
controls:5.88%
—
—
cases:14.29%
controls:5.89%
cases:41.46%
controls:27.35%
cases:53.42%
controls:54.82%
31
292
53
542
33
212
51
622
19
49
65
785
—
12
49
72
783
34
224
48
595
39
404
34
333
Hemoglobin [Mass/volume] in Blood
718-7 [3000963]
8.2e-02
6.9e-01
1.5e+00
—
9.8e-01
6.8e-01
4.6e-03
cases:36.90%
controls:35.01%
cases:40.48%
controls:25.42%
cases:22.62%
controls:5.88%
—
—
cases:14.29%
controls:5.89%
cases:42.68%
controls:27.35%
cases:54.79%
controls:54.68%
31
292
53
542
34
212
50
622
19
49
65
785
—
12
49
72
783
35
224
47
595
40
403
33
334
MCV [Entitic mean volume] in Red Blood Cells
30428-7 [3024731]
8.2e-02
6.9e-01
1.5e+00
—
9.8e-01
6.8e-01
4.6e-03
cases:36.90%
controls:35.01%
cases:40.48%
controls:25.42%
cases:22.62%
controls:5.88%
—
—
cases:14.29%
controls:5.89%
cases:42.68%
controls:27.35%
cases:54.79%
controls:54.68%
31
292
53
542
34
212
50
622
19
49
65
785
—
12
49
72
783
35
224
47
595
40
403
33
334
Platelets [#/volume] in Blood
26515-7 [3007461]
8.7e-02
7.0e-01
1.5e+00
—
9.8e-01
6.9e-01
4.6e-03
cases:36.90%
controls:34.89%
cases:40.48%
controls:25.30%
cases:22.62%
controls:5.88%
—
—
cases:14.29%
controls:5.89%
cases:42.68%
controls:27.23%
cases:54.79%
controls:54.68%
31
291
53
543
34
211
50
623
19
49
65
785
—
12
49
72
783
35
223
47
596
40
403
33
334
Erythrocyte [DistWidth] in Red Blood Cells
30385-9 [3002385]
1.6e-01
6.4e-01
1.5e+00
—
8.5e-01
4.3e-01
2.5e-01
cases:26.19%
controls:23.26%
cases:26.19%
controls:15.83%
cases:14.29%
controls:3.60%
—
—
cases:8.33%
controls:3.73%
cases:24.39%
controls:17.34%
cases:42.47%
controls:36.50%
22
194
62
640
22
132
62
702
12
30
72
804
—
7
31
77
801
20
142
62
677
31
269
42
468
prednisolone
A07EA01 [21600653]
1.1e+00
1.2e+00
—
—
—
1.4e+00
4.6e-01
cases:15.48%
controls:6.00%
cases:13.10%
controls:4.20%
—
—
—
—
—
—
cases:12.20%
controls:3.17%
cases:15.07%
controls:10.04%
13
50
71
784
11
35
73
799
—
—
—
10
26
72
793
11
74
62
663
prednisolone; oral, parenteral
H02AB06 [21602734]
1.1e+00
1.3e+00
—
—
—
1.4e+00
4.6e-01
cases:15.48%
controls:6.00%
cases:13.10%
controls:4.08%
—
—
—
—
—
—
cases:12.20%
controls:3.17%
cases:15.07%
controls:10.04%
13
50
71
784
11
34
73
800
—
—
—
10
26
72
793
11
74
62
663
Emergency Room Visit
ER [9203]
2.6e-01
1.4e+00
1.7e+00
1.0e+50
2.0e+00
9.2e-01
4.9e-02
cases:39.29%
controls:33.21%
cases:33.33%
controls:11.03%
cases:7.14%
controls:1.32%
cases:8.33%
controls:0.00%
cases:5.95%
controls:0.84%
cases:18.29%
controls:8.18%
cases:26.03%
controls:25.10%
33
277
51
557
28
92
56
742
6
11
78
823
7
0
77
834
5
7
79
825
15
67
67
752
19
185
54
552
mometasone; nasal
R01AD09 [21605051]
1.4e-01
—
—
—
—
7.6e-01
1.4e+00
cases:9.52%
controls:8.39%
—
—
—
—
—
—
—
—
cases:7.32%
controls:3.54%
cases:23.29%
controls:7.19%
8
70
76
764
—
—
—
—
6
29
76
790
17
53
56
684
Internal Medicine
11 [38004456]
1.0e-01
1.4e+00
—
1.0e+50
2.3e+00
1.1e+00
6.3e-01
cases:17.86%
controls:16.43%
cases:23.81%
controls:7.43%
—
—
cases:5.95%
controls:0.00%
cases:5.95%
controls:0.60%
cases:13.41%
controls:5.01%
cases:24.66%
controls:14.79%
15
137
69
697
20
62
64
772
—
5
0
79
834
5
5
79
827
11
41
71
778
18
109
55
628
Laboratory Visit
OMOP4822461 [32036]
-1.3e-01
4.8e-01
1.4e+00
—
5.6e-01
3.7e-01
1.0e-01
cases:38.10%
controls:41.25%
cases:48.81%
controls:37.17%
cases:32.14%
controls:10.91%
—
—
cases:20.24%
controls:12.62%
cases:47.56%
controls:38.46%
cases:64.38%
controls:62.01%
32
344
52
490
41
310
43
524
27
91
57
743
—
17
105
67
727
39
315
43
504
47
457
26
280
MCHC [Entitic Mass/volume] in Red Blood Cells
28540-3 [3003338]
-1.0e-01
5.4e-01
1.3e+00
—
1.1e+00
4.0e-01
-9.7e-02
cases:26.19%
controls:28.18%
cases:28.57%
controls:18.94%
cases:14.29%
controls:4.44%
—
—
cases:10.71%
controls:3.97%
cases:28.05%
controls:20.76%
cases:39.73%
controls:42.06%
22
235
62
599
24
158
60
676
12
37
72
797
—
9
33
75
799
23
170
59
649
29
310
44
427
cefalexin; oral
J01DB01 [21602870]
5.3e-01
1.2e+00
-1.0e+50
—
—
6.1e-01
4.2e-01
cases:40.48%
controls:28.66%
cases:25.00%
controls:8.75%
cases:0.00%
controls:0.96%
—
—
—
—
cases:14.63%
controls:8.55%
cases:35.62%
controls:26.59%
34
239
50
595
21
73
63
761
0
8
84
826
—
—
12
70
70
749
26
196
47
541
aPTT in Platelet poor plasma by Coagulation assay
14979-9 [3018677]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:1.90%
—
—
—
—
—
—
0
14
73
723
Planned health check-up monitoring, health check-up performed based on individual need
SPAT1317 [2001700418]
—
-1.0e+50
—
—
—
-1.0e+50
—
—
—
cases:0.00%
controls:0.96%
—
—
—
—
—
—
cases:0.00%
controls:0.73%
—
—
—
0
8
84
826
—
—
—
0
6
82
813
—
Ketones [Presence] in Urine by Test strip
2514-8 [3035350]
1.5e-01
1.1e+00
-1.0e+50
—
—
5.5e-01
-1.7e-01
cases:7.14%
controls:6.24%
cases:13.10%
controls:4.56%
cases:0.00%
controls:0.72%
—
—
—
—
cases:8.54%
controls:5.13%
cases:12.33%
controls:14.25%
6
52
78
782
11
38
73
796
0
6
84
828
—
—
7
42
75
777
9
105
64
632
Hemoglobin [Mass/volume] in Venous blood
30350-3 [3004119]
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.61%
—
—
—
—
—
—
—
0
5
82
814
—
paracetamol, combinations excl. psycholeptics
N02BE51 [21604348]
7.2e-01
—
—
—
—
—
—
cases:7.14%
controls:3.60%
—
—
—
—
—
—
—
—
—
—
—
—
6
30
78
804
—
—
—
—
—
—
Cervicobrachial syndrome
M53.1 [45567577]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:1.44%
—
—
—
—
—
—
—
—
—
—
—
—
0
12
84
822
—
—
—
—
—
—
Provision of consultation response
SPAT1285 [2001700386]
-1.0e+50
—
—
—
—
—
-1.0e+50
cases:0.00%
controls:0.72%
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.68%
0
6
84
828
—
—
—
—
—
0
5
73
732
dexchlorpheniramine, combinations
R06AB52 [21603467]
—
-1.0e+50
—
—
—
—
—
—
—
cases:0.00%
controls:0.72%
—
—
—
—
—
—
—
—
—
—
—
0
6
84
828
—
—
—
—
—
Spontaneous vertex delivery
O80.0 [45577661]
—
-1.0e+50
—
—
—
—
—
—
—
cases:0.00%
controls:0.72%
—
—
—
—
—
—
—
—
—
—
—
0
6
84
828
—
—
—
—
—
Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
70200-1 [42868674]
—
-1.0e+50
—
—
—
-1.0e+50
—
—
—
cases:0.00%
controls:1.32%
—
—
—
—
—
—
cases:0.00%
controls:1.10%
—
—
—
0
11
84
823
—
—
—
0
9
82
810
—
Deviated nasal septum
J34.2 [45562448]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.60%
—
—
—
—
—
—
—
—
—
—
—
—
0
5
84
829
—
—
—
—
—
—
Periodontal treatment by dental hygienist, very extensive
SDE04 [2001310352]
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.61%
—
—
—
—
—
—
—
0
5
82
814
—
cough suppressants and expectorants
R05FB02 [21603442]
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.61%
—
—
—
—
—
—
—
0
5
82
814
—
rivaroxaban; oral
B01AF01 [43534761]
-1.0e+50
—
—
—
—
-1.0e+50
—
cases:0.00%
controls:1.68%
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.73%
—
—
0
14
84
820
—
—
—
—
0
6
82
813
—
azelaic acid; ointment
D10AX03 [21602314]
—
—
—
—
—
-1.0e+50
-1.0e+50
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.61%
cases:0.00%
controls:1.09%
—
—
—
—
—
0
5
82
814
0
8
73
729
Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
2865-4 [3015322]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.68%
—
—
—
—
—
—
0
5
73
732
Extensive examination of musculoskeletal system
SPAT1212 [2001700313]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.60%
—
—
—
—
—
—
—
—
—
—
—
—
0
5
84
829
—
—
—
—
—
—
Bicarbonate [Moles/volume] in Capillary blood
1961-2 [3015235]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.68%
—
—
—
—
—
—
0
5
73
732
Telephone prescription or other care instructions
WZB00 [2001310884]
4.0e-01
—
—
—
—
—
3.6e-01
cases:8.33%
controls:5.76%
—
—
—
—
—
—
—
—
—
—
cases:6.85%
controls:4.88%
7
48
77
786
—
—
—
—
—
5
36
68
701
Urgent procedure
ZXD05 [2001311386]
3.1e-01
-1.0e+50
—
—
—
—
—
cases:5.95%
controls:4.44%
cases:0.00%
controls:1.20%
—
—
—
—
—
—
—
—
—
—
5
37
79
797
0
10
84
824
—
—
—
—
—
Photocoagulation of retina
CKC12 [2001301394]
—
-1.0e+50
—
—
—
—
—
—
—
cases:0.00%
controls:0.60%
—
—
—
—
—
—
—
—
—
—
—
0
5
84
829
—
—
—
—
—
Neurology
13 [38004458]
9.7e-01
1.1e+00
—
—
—
1.0e+00
4.6e-01
cases:15.48%
controls:6.47%
cases:9.52%
controls:3.48%
—
—
—
—
—
—
cases:7.32%
controls:2.81%
cases:10.96%
controls:7.19%
13
54
71
780
8
29
76
805
—
—
—
6
23
76
796
8
53
65
684
Chest pain, unspecified
R07.4 [45558450]
—
—
—
—
—
—
8.9e-01
—
—
—
—
—
—
—
—
—
—
—
—
cases:8.22%
controls:3.53%
—
—
—
—
—
—
6
26
67
711
betamethasone
D07AC01 [21602120]
—
—
—
—
—
-1.0e+50
-1.0e+50
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:2.93%
cases:0.00%
controls:6.51%
—
—
—
—
—
0
24
82
795
0
48
73
689
Optical coherence tomography (OCT) of ocular fundus
CK2X4 [2001301456]
-1.0e+50
—
—
—
—
-1.0e+50
—
cases:0.00%
controls:0.60%
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.73%
—
—
0
5
84
829
—
—
—
—
0
6
82
813
—
Myoglobin [Mass/volume] in Serum or Plasma
2639-3 [3005895]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.81%
—
—
—
—
—
—
0
6
73
731
C peptide [Moles/volume] in Serum or Plasma --fasting
42180-0 [3032836]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.96%
—
—
—
—
—
—
—
—
—
—
—
—
0
8
84
826
—
—
—
—
—
—
epinephrine; parenteral
C01CA24 [21600303]
—
-1.0e+50
—
—
—
—
—
—
—
cases:0.00%
controls:0.60%
—
—
—
—
—
—
—
—
—
—
—
0
5
84
829
—
—
—
—
—
Observation for suspected nervous system disorder
Z03.3 [45609903]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.68%
—
—
—
—
—
—
0
5
73
732
Protein [Mass/volume] in Urine
2888-6 [3037121]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.84%
—
—
—
—
—
—
—
—
—
—
—
—
0
7
84
827
—
—
—
—
—
—
Sterilization
Z30.2 [45609921]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.60%
—
—
—
—
—
—
—
—
—
—
—
—
0
5
84
829
—
—
—
—
—
—
Biopsy of skin and subcutaneous tissue
TQX10 [2001310152]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.68%
—
—
—
—
—
—
0
5
73
732
Tissue Pathology biopsy report
66121-5 [40768804]
-7.0e-02
—
—
—
—
1.3e+00
5.2e-01
cases:5.95%
controls:6.35%
—
—
—
—
—
—
—
—
cases:7.32%
controls:2.08%
cases:10.96%
controls:6.78%
5
53
79
781
—
—
—
—
6
17
76
802
8
50
65
687
Lumbar spine X-ray examination without contrast
NA3AA [2001307026]
-1.0e+50
-1.0e+50
—
—
—
—
-1.0e+50
cases:0.00%
controls:1.56%
cases:0.00%
controls:0.96%
—
—
—
—
—
—
—
—
cases:0.00%
controls:1.63%
0
13
84
821
0
8
84
826
—
—
—
—
0
12
73
725
felodipine; oral
C08CA02 [21601748]
-1.0e+50
-1.0e+50
—
—
—
-1.0e+50
-1.0e+50
cases:0.00%
controls:1.32%
cases:0.00%
controls:0.60%
—
—
—
—
—
—
cases:0.00%
controls:0.61%
cases:0.00%
controls:0.95%
0
11
84
823
0
5
84
829
—
—
—
0
5
82
814
0
7
73
730
DNA double strand Ab [Units/volume] in Serum
5130-0 [3023420]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:1.36%
—
—
—
—
—
—
0
10
73
727
Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
14685-2 [3009035]
—
-1.0e+50
—
—
—
—
3.0e-01
—
—
cases:0.00%
controls:0.60%
—
—
—
—
—
—
—
—
cases:6.85%
controls:5.16%
—
0
5
84
829
—
—
—
—
5
38
68
699
Specialty-specific consultation based on referral by dentist or doctor
WZC05 [2001310886]
-1.0e+50
—
—
—
—
—
-1.0e+50
cases:0.00%
controls:0.60%
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.68%
0
5
84
829
—
—
—
—
—
0
5
73
732
Glucose [Moles/volume] in Cerebral spinal fluid
14744-7 [3020044]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.68%
—
—
—
—
—
—
0
5
73
732
Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
3209-4 [3019250]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.81%
—
—
—
—
—
—
0
6
73
731
Personal history of diseases of the digestive system
Z87.1 [45542474]
-3.9e-02
—
—
—
—
-1.0e+50
2.8e-01
cases:8.33%
controls:8.63%
—
—
—
—
—
—
—
—
cases:0.00%
controls:3.79%
cases:12.33%
controls:9.63%
7
72
77
762
—
—
—
—
0
31
82
788
9
71
64
666
lidocaine; ointment
D04AB01 [21602020]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.68%
—
—
—
—
—
—
0
5
73
732
Tissue transglutaminase IgA Ab [Units/volume] in Serum
31017-7 [3019050]
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:1.59%
—
—
—
—
—
—
—
0
13
82
806
—
Benzodiazepines [Presence] in Urine
3390-2 [3000764]
—
-1.0e+50
—
—
—
—
-1.0e+50
—
—
cases:0.00%
controls:0.60%
—
—
—
—
—
—
—
—
cases:0.00%
controls:2.04%
—
0
5
84
829
—
—
—
—
0
15
73
722
Exposure to other specified factors
X58 [45756411]
—
—
—
—
—
-1.0e+50
-1.0e+50
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.73%
cases:0.00%
controls:2.31%
—
—
—
—
—
0
6
82
813
0
17
73
720
Fever, unspecified
R50.9 [45582716]
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.73%
—
—
—
—
—
—
—
0
6
82
813
—
SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
94500-6 [706163]
2.4e-02
7.3e-02
—
—
—
3.3e-01
6.7e-02
cases:13.10%
controls:12.83%
cases:8.33%
controls:7.79%
—
—
—
—
—
—
cases:7.32%
controls:5.37%
cases:23.29%
controls:22.12%
11
107
73
727
7
65
77
769
—
—
—
6
44
76
775
17
163
56
574
False labour before 37 completed weeks of gestation
O47.0 [45582556]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:1.32%
—
—
—
—
—
—
—
—
—
—
—
—
0
11
84
823
—
—
—
—
—
—
clidinium and psycholeptics
A03CA02 [21600204]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:1.09%
—
—
—
—
—
—
0
8
73
729
Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
19072-8 [3016431]
-4.5e-01
5.6e-01
-1.0e+50
—
—
6.5e-01
-1.2e-01
cases:5.95%
controls:8.99%
cases:7.14%
controls:4.20%
cases:0.00%
controls:0.96%
—
—
—
—
cases:8.54%
controls:4.64%
cases:10.96%
controls:12.21%
5
75
79
759
6
35
78
799
0
8
84
826
—
—
7
38
75
781
8
90
65
647
Suture or treatment of traumatic wound
SPAT1149 [2001700250]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:1.63%
—
—
—
—
—
—
0
12
73
725
More than one and less than three hours
ZXE10 [2001311401]
3.2e-01
—
—
—
—
—
—
cases:7.14%
controls:5.28%
—
—
—
—
—
—
—
—
—
—
—
—
6
44
78
790
—
—
—
—
—
—
Body temperature
8310-5 [3020891]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.95%
—
—
—
—
—
—
0
7
73
730
Emergency Room and Inpatient Visit
ERIP [262]
8.2e-01
—
—
—
—
—
—
cases:8.33%
controls:3.84%
—
—
—
—
—
—
—
—
—
—
—
—
7
32
77
802
—
—
—
—
—
—
Other somatoform disorders
F45.8 [45600750]
-1.0e+50
—
—
—
—
—
-1.0e+50
cases:0.00%
controls:0.72%
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.68%
0
6
84
828
—
—
—
—
—
0
5
73
732
Telehealth
OMOP5556618 [722455]
-2.3e-01
3.7e-01
—
—
—
9.6e-02
-7.0e-03
cases:19.05%
controls:22.90%
cases:10.71%
controls:7.67%
—
—
—
—
—
—
cases:8.54%
controls:7.81%
cases:17.81%
controls:17.91%
16
191
68
643
9
64
75
770
—
—
—
7
64
75
755
13
132
60
605
ondansetron; oral, parenteral, rectal
A04AA01 [21600493]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.95%
—
—
—
—
—
—
0
7
73
730
Supraglottic ventilation device
WX702 [2001310818]
-1.0e+50
—
—
—
—
—
-1.0e+50
cases:0.00%
controls:0.60%
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.81%
0
5
84
829
—
—
—
—
—
0
6
73
731
Dental X-ray, bite-wing X-ray on one side of the mouth
EB1SA [2001301918]
3.4e-02
2.8e-01
—
—
—
-1.0e+50
1.7e-01
cases:13.10%
controls:12.71%
cases:5.95%
controls:4.56%
—
—
—
—
—
—
cases:0.00%
controls:3.66%
cases:17.81%
controls:15.47%
11
106
73
728
5
38
79
796
—
—
—
0
30
82
789
13
114
60
623
Chalazion
H00.1 [45542919]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.81%
—
—
—
—
—
—
0
6
73
731
Other physical therapy
Z50.1 [45600331]
-1.0e+50
—
—
—
—
—
-1.0e+50
cases:0.00%
controls:0.60%
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.95%
0
5
84
829
—
—
—
—
—
0
7
73
730
Glucose tolerance 2 hours gestational panel - Serum or Plasma
81324-6 [21492888]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.60%
—
—
—
—
—
—
—
—
—
—
—
—
0
5
84
829
—
—
—
—
—
—
Osteoarthrosis of knee
L90 [2002000709]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.68%
—
—
—
—
—
—
0
5
73
732
Restricted oral and dental health check by dental hygienist or dental assistant
SAB01 [2001310279]
-1.0e+50
—
—
—
—
—
-1.0e+50
cases:0.00%
controls:1.92%
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:1.36%
0
16
84
818
—
—
—
—
—
0
10
73
727
Neoplasm of uncertain or unknown behaviour: Skin
D48.5 [45586113]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.60%
—
—
—
—
—
—
—
—
—
—
—
—
0
5
84
829
—
—
—
—
—
—
Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
48065-7 [3051714]
—
—
—
—
—
-1.0e+50
7.1e-01
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:1.22%
cases:8.22%
controls:4.21%
—
—
—
—
—
0
10
82
809
6
31
67
706
chloramphenicol; ointment
D06AX02 [21602063]
—
-1.0e+50
—
—
—
—
-1.0e+50
—
—
cases:0.00%
controls:0.60%
—
—
—
—
—
—
—
—
cases:0.00%
controls:1.09%
—
0
5
84
829
—
—
—
—
0
8
73
729
Feeling ill
A05 [2002000146]
-1.0e+50
—
—
—
—
—
-1.0e+50
cases:0.00%
controls:0.72%
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.81%
0
6
84
828
—
—
—
—
—
0
6
73
731
bupropion; oral
N06AX12 [21604741]
—
-1.0e+50
—
—
—
—
-1.0e+50
—
—
cases:0.00%
controls:0.60%
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.95%
—
0
5
84
829
—
—
—
—
0
7
73
730
Rotator cuff syndrome
M75.1 [45596678]
—
—
—
—
—
—
5.1e-01
—
—
—
—
—
—
—
—
—
—
—
—
cases:6.85%
controls:4.21%
—
—
—
—
—
—
5
31
68
706
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)
346 [2001600307]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.68%
—
—
—
—
—
—
0
5
73
732
Standard cardiac ultrasound examination
FM1AE [2001303278]
1.6e+00
—
—
—
—
—
—
cases:5.95%
controls:1.20%
—
—
—
—
—
—
—
—
—
—
—
—
5
10
79
824
—
—
—
—
—
—
Crystals [Presence] in Synovial fluid by Light microscopy
38458-6 [3050238]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.68%
—
—
—
—
—
—
0
5
73
732
chlorhexidine
S02AA09 [21605155]
1.0e+00
—
—
—
—
—
-1.0e+50
cases:7.14%
controls:2.64%
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:2.17%
6
22
78
812
—
—
—
—
—
0
16
73
721
Other specified urinary incontinence
N39.4 [45577525]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.84%
—
—
—
—
—
—
—
—
—
—
—
—
0
7
84
827
—
—
—
—
—
—
Acute upper respiratory infection, unspecified
J06.9 [45562437]
5.5e-01
4.7e-01
—
—
—
9.1e-01
3.5e-01
cases:15.48%
controls:9.59%
cases:8.33%
controls:5.40%
—
—
—
—
—
—
cases:9.76%
controls:4.15%
cases:19.18%
controls:14.38%
13
80
71
754
7
45
77
789
—
—
—
8
34
74
785
14
106
59
631
Issue of medical certificate
Z02.7 [45537613]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:1.76%
—
—
—
—
—
—
0
13
73
724
Influenza virus A Ag [Presence] in Specimen
31859-2 [3002523]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.60%
—
—
—
—
—
—
—
—
—
—
—
—
0
5
84
829
—
—
—
—
—
—
brompheniramine, combinations
R06AB51 [21603466]
—
-1.0e+50
—
—
—
—
—
—
—
cases:0.00%
controls:1.08%
—
—
—
—
—
—
—
—
—
—
—
0
9
84
825
—
—
—
—
—
Drugs identified in Urine by Screen method Nominal
12286-1 [3011288]
-1.0e+50
—
—
—
—
—
-1.0e+50
cases:0.00%
controls:1.20%
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:1.36%
0
10
84
824
—
—
—
—
—
0
10
73
727
Office Visit
OMOP4822458 [581477]
-2.2e-02
8.2e-01
—
—
—
6.8e-01
-3.4e-01
cases:9.52%
controls:9.71%
cases:9.52%
controls:4.44%
—
—
—
—
—
—
cases:6.10%
controls:3.17%
cases:6.85%
controls:9.36%
8
81
76
753
8
37
76
797
—
—
—
5
26
77
793
5
69
68
668
Puncture of vitreous body with injection of medication
CKD05 [2001301407]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:1.09%
—
—
—
—
—
—
0
8
73
729
warfarin; oral, parenteral
B01AA03 [21600965]
—
—
—
—
—
—
1.7e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:6.85%
controls:1.36%
—
—
—
—
—
—
5
10
68
727
Neutrophils/Leukocytes in Blood
26511-6 [3018010]
2.6e-01
5.7e-01
2.2e+00
—
—
1.7e-01
-8.9e-02
cases:14.29%
controls:11.39%
cases:9.52%
controls:5.64%
cases:5.95%
controls:0.72%
—
—
—
—
cases:7.32%
controls:6.23%
cases:13.70%
controls:14.79%
12
95
72
739
8
47
76
787
5
6
79
828
—
—
6
51
76
768
10
109
63
628
Contusion of thorax
S20.2 [45597402]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.68%
—
—
—
—
—
—
0
5
73
732
mirabegron; oral
G04BD12 [43534790]
-1.0e+50
—
—
—
—
—
-1.0e+50
cases:0.00%
controls:0.72%
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.95%
0
6
84
828
—
—
—
—
—
0
7
73
730
guar gum
A10BX01 [21600789]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.60%
—
—
—
—
—
—
—
—
—
—
—
—
0
5
84
829
—
—
—
—
—
—
Measurement of mechanical axis of lower leg with X-ray
NJ2MA [2001308419]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.95%
—
—
—
—
—
—
0
7
73
730
valproic acid; oral, parenteral, rectal
N03AG01 [21604422]
—
—
-1.0e+50
—
-1.0e+50
—
-1.0e+50
—
—
—
—
cases:0.00%
controls:0.72%
—
—
cases:0.00%
controls:0.96%
—
—
cases:0.00%
controls:1.63%
—
—
0
6
84
828
—
0
8
84
824
—
0
12
73
725
hydrocortisone and antiinfectives
S02CA03 [21605175]
9.4e-01
—
—
—
—
—
—
cases:5.95%
controls:2.40%
—
—
—
—
—
—
—
—
—
—
—
—
5
20
79
814
—
—
—
—
—
—
Foreign body in skin
S15 [2002000980]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.60%
—
—
—
—
—
—
—
—
—
—
—
—
0
5
84
829
—
—
—
—
—
—
Health check-up performed during second study year in students of upper secondary schools, vocational schools etc.
SPAT1364 [2001700465]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.60%
—
—
—
—
—
—
—
—
—
—
—
—
0
5
84
829
—
—
—
—
—
—
Remote contact by phone
ZYC01 [2001311579]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.95%
—
—
—
—
—
—
0
7
73
730
ezetimibe; oral
C10AX09 [21601896]
—
-1.0e+50
—
—
—
-1.0e+50
-1.0e+50
—
—
cases:0.00%
controls:0.60%
—
—
—
—
—
—
cases:0.00%
controls:0.85%
cases:0.00%
controls:3.26%
—
0
5
84
829
—
—
—
0
7
82
812
0
24
73
713
Basophils/Leukocytes in Blood
30180-4 [3022096]
2.7e-01
8.4e-01
2.2e+00
—
—
4.9e-01
-1.1e-01
cases:14.29%
controls:11.27%
cases:11.90%
controls:5.52%
cases:5.95%
controls:0.72%
—
—
—
—
cases:9.76%
controls:6.23%
cases:13.70%
controls:15.06%
12
94
72
740
10
46
74
788
5
6
79
828
—
—
8
51
74
768
10
111
63
626
Intraoperative use of conventional X-ray imaging
ZXM10 [2001311446]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:1.08%
—
—
—
—
—
—
—
—
—
—
—
—
0
9
84
825
—
—
—
—
—
—
Excessive attrition of teeth
K03.0 [45601139]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.60%
—
—
—
—
—
—
—
—
—
—
—
—
0
5
84
829
—
—
—
—
—
—
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
117 [2001600117]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.72%
—
—
—
—
—
—
—
—
—
—
—
—
0
6
84
828
—
—
—
—
—
—
Intravenous sedation or analgesia without general anesthesia
WX006 [2001310762]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.95%
—
—
—
—
—
—
0
7
73
730
calcium carbonate; oral
A12AA04 [21600863]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.60%
—
—
—
—
—
—
—
—
—
—
—
—
0
5
84
829
—
—
—
—
—
—
Naevus/mole
S82 [2002001046]
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.73%
—
—
—
—
—
—
—
0
6
82
813
—
Split tooth for reasons other than trauma
K03.82 [2000502700]
—
-1.0e+50
—
—
—
—
—
—
—
cases:0.00%
controls:0.84%
—
—
—
—
—
—
—
—
—
—
—
0
7
84
827
—
—
—
—
—
Mixed specific developmental disorders
F83 [45595922]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.60%
—
—
—
—
—
—
—
—
—
—
—
—
0
5
84
829
—
—
—
—
—
—
dapagliflozin; oral
A10BK01 [1123890]
-1.0e+50
-1.0e+50
—
—
-1.0e+50
-1.0e+50
-1.0e+50
cases:0.00%
controls:0.72%
cases:0.00%
controls:0.72%
—
—
—
—
cases:0.00%
controls:0.60%
cases:0.00%
controls:0.85%
cases:0.00%
controls:1.49%
0
6
84
828
0
6
84
828
—
—
0
5
84
827
0
7
82
812
0
11
73
726
Ophthalmology
18 [38004463]
3.0e-01
7.4e-01
—
—
—
7.7e-01
1.3e-01
cases:14.29%
controls:11.03%
cases:9.52%
controls:4.80%
—
—
—
—
—
—
cases:10.98%
controls:5.37%
cases:16.44%
controls:14.79%
12
92
72
742
8
40
76
794
—
—
—
9
44
73
775
12
109
61
628
dexamethasone
D10AA03 [21602286]
—
-1.0e+50
—
—
—
—
-1.0e+50
—
—
cases:0.00%
controls:0.60%
—
—
—
—
—
—
—
—
cases:0.00%
controls:1.09%
—
0
5
84
829
—
—
—
—
0
8
73
729
Clinical & Laboratory Dermatological Immunology Physician
207NI0002X [38003841]
1.0e-02
—
—
—
—
—
2.9e-01
cases:7.14%
controls:7.07%
—
—
—
—
—
—
—
—
—
—
cases:10.96%
controls:8.41%
6
59
78
775
—
—
—
—
—
8
62
65
675
insulin (beef); parenteral
A10AD02 [21600730]
-1.0e+50
-1.0e+50
-1.0e+50
—
-1.0e+50
—
—
cases:0.00%
controls:3.36%
cases:0.00%
controls:3.48%
cases:0.00%
controls:1.08%
—
—
cases:0.00%
controls:1.20%
—
—
—
—
0
28
84
806
0
29
84
805
0
9
84
825
—
0
10
84
822
—
—
isosorbide mononitrate; oral
C01DA14 [21600324]
-1.0e+50
—
—
—
—
—
-1.0e+50
cases:0.00%
controls:0.60%
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.95%
0
5
84
829
—
—
—
—
—
0
7
73
730
adalimumab; parenteral
L04AB04 [21603911]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.68%
—
—
—
—
—
—
0
5
73
732
Epithelial cells.non-squamous [#/volume] in Urine by Automated count
51485-1 [3030306]
—
—
—
—
—
—
7.0e-01
—
—
—
—
—
—
—
—
—
—
—
—
cases:6.85%
controls:3.53%
—
—
—
—
—
—
5
26
68
711
Excessive and frequent menstruation with regular cycle
N92.0 [45577544]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:1.08%
—
—
—
—
—
—
—
—
—
—
—
—
0
9
84
825
—
—
—
—
—
—
Pediatric Gastroenterology
OMOP4822029 [45756810]
—
—
—
—
—
-1.0e+50
-1.0e+50
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.61%
cases:0.00%
controls:0.81%
—
—
—
—
—
0
5
82
814
0
6
73
731
Noninvasive ventilation
WX725 [2001310828]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.68%
—
—
—
—
—
—
0
5
73
732
Chest pain NOS
A11 [2002000152]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.72%
—
—
—
—
—
—
—
—
—
—
—
—
0
6
84
828
—
—
—
—
—
—
Other Crohn disease
K50.8 [45533599]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.68%
—
—
—
—
—
—
0
5
73
732
Other obstetric ultrasound examination
MA2XE [2001306838]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.68%
—
—
—
—
—
—
0
5
73
732
Fasting glucose [Moles/volume] in Serum or Plasma
14771-0 [3018251]
1.1e-01
4.5e-03
—
—
-1.0e+50
1.2e-01
1.3e-01
cases:21.43%
controls:19.66%
cases:10.71%
controls:10.67%
—
—
—
—
cases:0.00%
controls:1.68%
cases:13.41%
controls:12.09%
cases:36.99%
controls:33.92%
18
164
66
670
9
89
75
745
—
—
0
14
84
818
11
99
71
720
27
250
46
487
Laboratory test
15220000 [4034850]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:2.16%
—
—
—
—
—
—
—
—
—
—
—
—
0
18
84
816
—
—
—
—
—
—
Gynecological ultrasound examination as part of clinical examination
LX1AE [2001306815]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:1.09%
—
—
—
—
—
—
0
8
73
729
Oral and dental health check by dental hygienist or dental assistant
SAB02 [2001310280]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.81%
—
—
—
—
—
—
0
6
73
731
Tear of meniscus, current
S83.2 [45555441]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.68%
—
—
—
—
—
—
0
5
73
732
fexofenadine; oral
R06AX26 [21603525]
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.61%
—
—
—
—
—
—
—
0
5
82
814
—
Gastro-oesophageal reflux disease
K21 [45586708]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.60%
—
—
—
—
—
—
—
—
—
—
—
—
0
5
84
829
—
—
—
—
—
—
Fracture of rib
S22.3 [45573285]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.68%
—
—
—
—
—
—
0
5
73
732
Internal hemorrhoids without complication
I84.2 [45596267]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.60%
—
—
—
—
—
—
—
—
—
—
—
—
0
5
84
829
—
—
—
—
—
—
Hospital outpatient
ZY010 [2001311599]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.81%
—
—
—
—
—
—
0
6
73
731
Dysthymia
F34.1 [45586238]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.60%
—
—
—
—
—
—
—
—
—
—
—
—
0
5
84
829
—
—
—
—
—
—
Cervical spine MRI examination with high intensity magnet
NA1BG [2001306990]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.68%
—
—
—
—
—
—
0
5
73
732
General Surgery
2 [38004447]
5.9e-01
9.7e-01
—
—
—
7.2e-01
4.5e-01
cases:21.43%
controls:13.19%
cases:9.52%
controls:3.84%
—
—
—
—
—
—
cases:6.10%
controls:3.05%
cases:16.44%
controls:11.13%
18
110
66
724
8
32
76
802
—
—
—
5
25
77
794
12
82
61
655
Prealbumin [Mass/volume] in Serum or Plasma
14338-8 [3013742]
-1.0e+50
-1.0e+50
—
—
—
-1.0e+50
—
cases:0.00%
controls:1.20%
cases:0.00%
controls:0.96%
—
—
—
—
—
—
cases:0.00%
controls:0.61%
—
—
0
10
84
824
0
8
84
826
—
—
—
0
5
82
814
—
Other oral or dental procedure
SXC05 [2001310586]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:2.28%
—
—
—
—
—
—
—
—
—
—
—
—
0
19
84
815
—
—
—
—
—
—
Nutritional therapy
R4190 [2001310243]
-1.0e+50
—
—
—
—
—
-1.0e+50
cases:0.00%
controls:1.44%
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.95%
0
12
84
822
—
—
—
—
—
0
7
73
730
Cardiac arrhythmia, unspecified
I49.9 [45581778]
-1.0e+50
—
—
—
—
—
-1.0e+50
cases:0.00%
controls:1.08%
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:1.76%
0
9
84
825
—
—
—
—
—
0
13
73
724
Hand Surgery
40 [38004480]
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.98%
—
—
—
—
—
—
—
0
8
82
811
—
rabeprazole; oral
A02BC04 [21600099]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.96%
—
—
—
—
—
—
—
—
—
—
—
—
0
8
84
826
—
—
—
—
—
—
Apolipoprotein B [Mass/volume] in Serum or Plasma
1884-6 [3014791]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:1.09%
—
—
—
—
—
—
0
8
73
729
Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
14928-6 [3026989]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:1.92%
—
—
—
—
—
—
—
—
—
—
—
—
0
16
84
818
—
—
—
—
—
—
Chronic alcohol abuse
P15 [2002000811]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.68%
—
—
—
—
—
—
0
5
73
732
Wrist X-ray examination
ND1AA [2001307576]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.72%
—
—
—
—
—
—
—
—
—
—
—
—
0
6
84
828
—
—
—
—
—
—
SMOKING - SMOKE2: no - SMOKE3: former - SMOKE5: former
SMOKING-2-2-4 [2002330109]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:1.56%
—
—
—
—
—
—
—
—
—
—
—
—
0
13
84
821
—
—
—
—
—
—
Examination of eyes and vision
Z01.0 [45566391]
9.4e-01
—
—
—
—
—
9.2e-01
cases:5.95%
controls:2.40%
—
—
—
—
—
—
—
—
—
—
cases:6.85%
controls:2.85%
5
20
79
814
—
—
—
—
—
5
21
68
716
Panorama tomography of teeth and jaws or similar X-ray examination
EB1HA [2001301913]
—
1.1e+00
—
—
—
—
2.3e-01
—
—
cases:5.95%
controls:2.04%
—
—
—
—
—
—
—
—
cases:9.59%
controls:7.73%
—
5
17
79
817
—
—
—
—
7
57
66
680
Other specified special examinations
Z01.8 [45581003]
—
-1.0e+50
—
—
—
—
—
—
—
cases:0.00%
controls:0.72%
—
—
—
—
—
—
—
—
—
—
—
0
6
84
828
—
—
—
—
—
Diverticular disease of large intestine without perforation or abscess
K57.3 [45567316]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:2.04%
—
—
—
—
—
—
0
15
73
722
SMOKING - SMOKE2: yes - SMOKE3: current - SMOKE5: Unspecified
SMOKING-1-1-0 [2002330116]
—
-1.0e+50
—
—
—
—
—
—
—
cases:0.00%
controls:0.84%
—
—
—
—
—
—
—
—
—
—
—
0
7
84
827
—
—
—
—
—
Valproate [Moles/volume] in Serum or Plasma
14946-8 [3009466]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:1.22%
—
—
—
—
—
—
0
9
73
728
Cathetrisation of vein
TPH04 [2001309597]
-1.0e+50
—
—
—
—
—
-1.0e+50
cases:0.00%
controls:2.04%
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:3.39%
0
17
84
817
—
—
—
—
—
0
25
73
712
Cannabinoids [Presence] in Urine
3427-2 [3028300]
—
-1.0e+50
—
—
—
—
-1.0e+50
—
—
cases:0.00%
controls:0.60%
—
—
—
—
—
—
—
—
cases:0.00%
controls:2.04%
—
0
5
84
829
—
—
—
—
0
15
73
722
Forced vital capacity [Volume] Respiratory system
19870-5 [3020158]
—
—
—
—
—
—
2.0e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:6.85%
controls:0.95%
—
—
—
—
—
—
5
7
68
730
Tinnitus
H93.1 [45543152]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.72%
—
—
—
—
—
—
—
—
—
—
—
—
0
6
84
828
—
—
—
—
—
—
Type 1 diabetes mellitus, With multiple complications
E10.7 [45571655]
-1.0e+50
-1.0e+50
—
—
—
—
-1.0e+50
cases:0.00%
controls:0.84%
cases:0.00%
controls:0.72%
—
—
—
—
—
—
—
—
cases:0.00%
controls:1.36%
0
7
84
827
0
6
84
828
—
—
—
—
0
10
73
727
Myelocytes/Leukocytes in Blood
26498-6 [3017181]
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.61%
—
—
—
—
—
—
—
0
5
82
814
—
First degree haemorrhoids
K64.0 [45548166]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.81%
—
—
—
—
—
—
0
6
73
731
Plain photography of ocular fundus
CK2S4 [2001301455]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.95%
—
—
—
—
—
—
0
7
73
730
Child-centred family therapy
IEP02 [2001304194]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.72%
—
—
—
—
—
—
—
—
—
—
—
—
0
6
84
828
—
—
—
—
—
—
desloratadine; oral
R06AX27 [21603526]
6.6e-02
—
—
—
—
—
1.0e-01
cases:7.14%
controls:6.71%
—
—
—
—
—
—
—
—
—
—
cases:8.22%
controls:7.46%
6
56
78
778
—
—
—
—
—
6
55
67
682
venlafaxine; oral
N06AX16 [21604745]
—
-1.0e+50
—
—
—
-1.0e+50
-1.0e+50
—
—
cases:0.00%
controls:1.08%
—
—
—
—
—
—
cases:0.00%
controls:1.10%
cases:0.00%
controls:2.58%
—
0
9
84
825
—
—
—
0
9
82
810
0
19
73
718
Cholesterol [Moles/volume] in Serum or Plasma
14647-2 [3019900]
1.5e-01
1.4e-01
—
—
-1.0e+50
-1.2e-01
-6.9e-02
cases:22.62%
controls:20.14%
cases:14.29%
controls:12.71%
—
—
—
—
cases:0.00%
controls:1.68%
cases:12.20%
controls:13.55%
cases:39.73%
controls:41.38%
19
168
65
666
12
106
72
728
—
—
0
14
84
818
10
111
72
708
29
305
44
432
Abdominal CT examination
JN3AD [2001305554]
-1.0e+50
—
—
—
—
—
-1.0e+50
cases:0.00%
controls:0.84%
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:2.44%
0
7
84
827
—
—
—
—
—
0
18
73
719
Pediatric Hematology-Oncology
OMOP4822028 [45756811]
-1.0e+50
-1.0e+50
—
—
—
-1.0e+50
—
cases:0.00%
controls:0.96%
cases:0.00%
controls:0.60%
—
—
—
—
—
—
cases:0.00%
controls:0.73%
—
—
0
8
84
826
0
5
84
829
—
—
—
0
6
82
813
—
ambroxol; oral
R05CB06 [21603385]
6.2e-01
—
—
—
—
-1.0e+50
—
cases:7.14%
controls:3.96%
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.73%
—
—
6
33
78
801
—
—
—
—
0
6
82
813
—
Sampling
SPAT1263 [2001700364]
—
—
—
—
—
—
-1.1e-01
—
—
—
—
—
—
—
—
—
—
—
—
cases:8.22%
controls:9.09%
—
—
—
—
—
—
6
67
67
670
Neutrophils [#/volume] in Blood
26499-4 [3017732]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:1.68%
—
—
—
—
—
—
—
—
—
—
—
—
0
14
84
820
—
—
—
—
—
—
chloramphenicol
S03AA08 [21605197]
1.5e-01
—
—
—
—
—
4.9e-01
cases:11.90%
controls:10.43%
—
—
—
—
—
—
—
—
—
—
cases:15.07%
controls:9.77%
10
87
74
747
—
—
—
—
—
11
72
62
665
Albumin [Mass/time] in Urine collected for unspecified duration
49002-9 [3050449]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.68%
—
—
—
—
—
—
0
5
73
732
fluvastatin; oral
C10AA04 [21601859]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.60%
—
—
—
—
—
—
—
—
—
—
—
—
0
5
84
829
—
—
—
—
—
—
Prolactin [Units/volume] in Serum or Plasma
15081-3 [3021387]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.81%
—
—
—
—
—
—
0
6
73
731
hydrocortisone
D07XA01 [21602180]
1.0e+00
—
—
—
—
—
-1.0e+50
cases:7.14%
controls:2.76%
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:2.17%
6
23
78
811
—
—
—
—
—
0
16
73
721
varicella, live attenuated
J07BK01 [21601362]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.95%
—
—
—
—
—
—
0
7
73
730
antibiotics in combination with other drugs
S01AA20 [21603571]
4.2e-01
—
—
—
—
—
—
cases:10.71%
controls:7.31%
—
—
—
—
—
—
—
—
—
—
—
—
9
61
75
773
—
—
—
—
—
—
Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
32730-4 [3043723]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.81%
—
—
—
—
—
—
0
6
73
731
Limited function/disability (L)
L28 [2002000647]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:2.31%
—
—
—
—
—
—
0
17
73
720
levothyroxine sodium; oral, parenteral
H03AA01 [21602754]
-3.2e-01
-1.3e-01
—
—
—
-5.4e-02
-1.1e-01
cases:5.95%
controls:8.03%
cases:7.14%
controls:8.03%
—
—
—
—
—
—
cases:7.32%
controls:7.69%
cases:8.22%
controls:9.09%
5
67
79
767
6
67
78
767
—
—
—
6
63
76
756
6
67
67
670
Abdominal ultrasound examination
JN3AE [2001305555]
-1.0e+50
—
—
—
—
-1.0e+50
—
cases:0.00%
controls:2.76%
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.61%
—
—
0
23
84
811
—
—
—
—
0
5
82
814
—
dexamethasone
S02BA06 [21605168]
—
-1.0e+50
—
—
—
—
-1.0e+50
—
—
cases:0.00%
controls:0.60%
—
—
—
—
—
—
—
—
cases:0.00%
controls:1.09%
—
0
5
84
829
—
—
—
—
0
8
73
729
FEV1 percent change
69983-5 [42868472]
—
—
—
—
—
—
2.0e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:6.85%
controls:0.95%
—
—
—
—
—
—
5
7
68
730
Influenza virus B Ag [Presence] in Specimen
31864-2 [3003740]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.60%
—
—
—
—
—
—
—
—
—
—
—
—
0
5
84
829
—
—
—
—
—
—
Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
29374-6 [3006999]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.95%
—
—
—
—
—
—
0
7
73
730
glucagon; nasal, parenteral
H04AA01 [21602778]
-1.0e+50
—
—
—
—
—
-1.0e+50
cases:0.00%
controls:0.96%
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.68%
0
8
84
826
—
—
—
—
—
0
5
73
732
Malaise and fatigue
R53 [45553741]
-1.0e+50
—
—
—
—
—
8.2e-01
cases:0.00%
controls:2.16%
—
—
—
—
—
—
—
—
—
—
cases:6.85%
controls:3.12%
0
18
84
816
—
—
—
—
—
5
23
68
714
Other allergic rhinitis
J30.3 [45538477]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.68%
—
—
—
—
—
—
0
5
73
732
Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
51435-6 [3029713]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.81%
—
—
—
—
—
—
0
6
73
731
escitalopram; oral
N06AB10 [21604718]
8.3e-01
1.4e+00
—
—
—
—
6.2e-01
cases:7.14%
controls:3.24%
cases:5.95%
controls:1.56%
—
—
—
—
—
—
—
—
cases:6.85%
controls:3.80%
6
27
78
807
5
13
79
821
—
—
—
—
5
28
68
709
simvastatin; oral
C10AA01 [21601856]
—
—
-1.0e+50
—
—
—
—
—
—
—
—
cases:0.00%
controls:1.20%
—
—
—
—
—
—
—
—
—
—
0
10
84
824
—
—
—
—
semaglutide; oral, parenteral
A10BJ06 [1501778]
-1.0e+50
-1.0e+50
—
—
—
-1.0e+50
—
cases:0.00%
controls:0.72%
cases:0.00%
controls:0.72%
—
—
—
—
—
—
cases:0.00%
controls:1.10%
—
—
0
6
84
828
0
6
84
828
—
—
—
0
9
82
810
—
Day surgery
ZXD20 [2001311388]
-1.0e+50
—
—
—
—
—
-1.0e+50
cases:0.00%
controls:0.72%
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:1.22%
0
6
84
828
—
—
—
—
—
0
9
73
728
Breathing problem other
R04 [2002000885]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.60%
—
—
—
—
—
—
—
—
—
—
—
—
0
5
84
829
—
—
—
—
—
—
Recurrent depression, moderate episode without somatic syndrome
F33.10 [2000501984]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:1.36%
—
—
—
—
—
—
0
10
73
727
Extended examination of mouth
SAA03 [2001310276]
1.8e-01
—
-1.0e+50
—
—
-1.0e+50
4.5e-01
cases:10.71%
controls:9.11%
—
—
cases:0.00%
controls:0.60%
—
—
—
—
cases:0.00%
controls:4.15%
cases:13.70%
controls:9.23%
9
76
75
758
—
0
5
84
829
—
—
0
34
82
785
10
68
63
669
Ultrasound examination of lower leg veins
PH2AE [2001309451]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:1.22%
—
—
—
—
—
—
0
9
73
728
Deposits [accretions] on teeth betel
K03.65 [2000502690]
—
-1.0e+50
—
—
—
-1.0e+50
-1.0e+50
—
—
cases:0.00%
controls:1.20%
—
—
—
—
—
—
cases:0.00%
controls:1.10%
cases:0.00%
controls:3.26%
—
0
10
84
824
—
—
—
0
9
82
810
0
24
73
713
Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1920-8 [3013721]
5.3e-01
—
—
—
—
—
-5.9e-01
cases:10.71%
controls:6.59%
—
—
—
—
—
—
—
—
—
—
cases:6.85%
controls:11.67%
9
55
75
779
—
—
—
—
—
5
86
68
651
Gas panel - Venous blood
24339-4 [3000991]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:2.76%
—
—
—
—
—
—
—
—
—
—
—
—
0
23
84
811
—
—
—
—
—
—
Infiltration anesthesia
WX110 [2001310767]
2.7e-01
2.5e-01
—
—
—
4.9e-01
2.9e-01
cases:23.81%
controls:19.30%
cases:9.52%
controls:7.55%
—
—
—
—
—
—
cases:13.41%
controls:8.67%
cases:27.40%
controls:21.98%
20
161
64
673
8
63
76
771
—
—
—
11
71
71
748
20
162
53
575
Acute pharyngitis, unspecified
J02.9 [45538472]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.68%
—
—
—
—
—
—
0
5
73
732
Chronic kidney disease
N18 [45582391]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.72%
—
—
—
—
—
—
—
—
—
—
—
—
0
6
84
828
—
—
—
—
—
—
Bloodpressure measurement
XF600 [2001303376]
-1.0e+50
—
—
—
—
—
-1.0e+50
cases:0.00%
controls:0.84%
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.81%
0
7
84
827
—
—
—
—
—
0
6
73
731
Spacing, abnormal of tooth or teeth
K07.30 [2000502776]
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.73%
—
—
—
—
—
—
—
0
6
82
813
—
candesartan and diuretics
C09DA06 [21601838]
—
—
-1.0e+50
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.60%
—
—
—
—
—
—
—
—
—
—
0
5
84
829
—
—
—
—
Biopsy of endometrium
LCA06 [2001306551]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:1.32%
—
—
—
—
—
—
—
—
—
—
—
—
0
11
84
823
—
—
—
—
—
—
Other and unspecified skin changes
R23.8 [45573020]
—
—
—
—
—
-1.0e+50
-1.0e+50
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.85%
cases:0.00%
controls:2.85%
—
—
—
—
—
0
7
82
812
0
21
73
716
Geriatric Medicine
38 [38004478]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.68%
—
—
—
—
—
—
0
5
73
732
COVID-19, virus not identified
U07.2 [45756094]
1.4e+00
—
—
—
—
—
—
cases:8.33%
controls:2.28%
—
—
—
—
—
—
—
—
—
—
—
—
7
19
77
815
—
—
—
—
—
—
codeine; oral
R05DA04 [21603399]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:2.17%
—
—
—
—
—
—
0
16
73
721
Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
7853-5 [3015635]
-1.0e+50
—
—
—
—
-1.0e+50
—
cases:0.00%
controls:0.72%
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.61%
—
—
0
6
84
828
—
—
—
—
0
5
82
814
—
Moderate depressive episode
F32.1 [45552478]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.72%
—
—
—
—
—
—
—
—
—
—
—
—
0
6
84
828
—
—
—
—
—
—
Mouth breathing
R06.5 [45573006]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.81%
—
—
—
—
—
—
0
6
73
731
Leukocyte morphology finding [Identifier] in Blood
11156-7 [3008757]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.60%
—
—
—
—
—
—
—
—
—
—
—
—
0
5
84
829
—
—
—
—
—
—
Otitis media, unspecified
H66.9 [45547965]
-1.0e+50
—
—
—
—
—
-1.0e+50
cases:0.00%
controls:1.20%
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:1.22%
0
10
84
824
—
—
—
—
—
0
9
73
728
Person encountering health services in unspecified circumstances
Z76.9 [45609967]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.84%
—
—
—
—
—
—
—
—
—
—
—
—
0
7
84
827
—
—
—
—
—
—
Short blood count panel - Blood
55429-5 [40758558]
1.6e-01
—
—
—
—
—
4.4e-01
cases:8.33%
controls:7.19%
—
—
—
—
—
—
—
—
—
—
cases:9.59%
controls:6.38%
7
60
77
774
—
—
—
—
—
7
47
66
690
Supervision of other normal pregnancy
Z34.8 [45537628]
—
-1.0e+50
—
—
—
—
—
—
—
cases:0.00%
controls:0.60%
—
—
—
—
—
—
—
—
—
—
—
0
5
84
829
—
—
—
—
—
finasteride; oral
D11AX10 [21602350]
-1.0e+50
-1.0e+50
—
—
—
—
-1.0e+50
cases:0.00%
controls:0.60%
cases:0.00%
controls:0.60%
—
—
—
—
—
—
—
—
cases:0.00%
controls:1.49%
0
5
84
829
0
5
84
829
—
—
—
—
0
11
73
726
azelastine; nasal
R01AC03 [21605035]
5.0e-01
—
—
—
—
—
3.6e-01
cases:7.14%
controls:4.44%
—
—
—
—
—
—
—
—
—
—
cases:6.85%
controls:4.88%
6
37
78
797
—
—
—
—
—
5
36
68
701
Bilirubin.conjugated [Moles/volume] in Serum or Plasma
29760-6 [3005772]
—
—
—
—
—
-1.0e+50
-1.0e+50
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.61%
cases:0.00%
controls:2.71%
—
—
—
—
—
0
5
82
814
0
20
73
717
clozapine; oral, parenteral
N05AH02 [21604542]
-1.0e+50
-1.0e+50
—
—
-1.0e+50
-1.0e+50
-1.0e+50
cases:0.00%
controls:0.72%
cases:0.00%
controls:0.72%
—
—
—
—
cases:0.00%
controls:0.72%
cases:0.00%
controls:0.61%
cases:0.00%
controls:0.81%
0
6
84
828
0
6
84
828
—
—
0
6
84
826
0
5
82
814
0
6
73
731
Neck ultrasound examination
EP1AE [2001302284]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:1.32%
—
—
—
—
—
—
—
—
—
—
—
—
0
11
84
823
—
—
—
—
—
—
Psychosocial counselling and guidance
SPAT1307 [2001700408]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:1.20%
—
—
—
—
—
—
—
—
—
—
—
—
0
10
84
824
—
—
—
—
—
—
Mugwort IgE Ab [Units/volume] in Serum
6183-8 [3008401]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.84%
—
—
—
—
—
—
—
—
—
—
—
—
0
7
84
827
—
—
—
—
—
—
Pure hypercholesterolaemia
E78.01 [2000501514]
-1.0e+50
—
—
—
—
-1.0e+50
—
cases:0.00%
controls:1.68%
—
—
—
—
—
—
—
—
cases:0.00%
controls:1.10%
—
—
0
14
84
820
—
—
—
—
0
9
82
810
—
Cough
R05 [2002000886]
—
—
—
—
—
—
1.1e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:8.22%
controls:2.85%
—
—
—
—
—
—
6
21
67
716
Sequestration of lung
Q33.2 [45606734]
—
—
—
1.0e+50
1.0e+50
1.0e+50
1.0e+50
—
—
—
—
—
—
cases:28.57%
controls:0.00%
cases:9.52%
controls:0.00%
cases:24.39%
controls:0.00%
cases:8.22%
controls:0.00%
—
—
—
24
0
60
834
8
0
76
832
20
0
62
819
6
0
67
737
Erythrocytes [Presence] in Urine by Automated
53292-9 [3041096]
—
1.6e+00
—
—
—
—
—
—
—
cases:8.33%
controls:1.80%
—
—
—
—
—
—
—
—
—
—
—
7
15
77
819
—
—
—
—
—
Prothrombin time (PT) actual/Normal
5894-1 [3033658]
—
—
—
—
—
1.6e+00
—
—
—
—
—
—
—
—
—
—
—
cases:7.32%
controls:1.59%
—
—
—
—
—
—
—
6
13
76
806
—
Monitored bed care
WX892 [2001310850]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.95%
—
—
—
—
—
—
0
7
73
730
Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
27811-9 [3000515]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.68%
—
—
—
—
—
—
0
5
73
732
Audiology
64 [38004489]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:2.04%
—
—
—
—
—
—
—
—
—
—
—
—
0
17
84
817
—
—
—
—
—
—
isotretinoin; oral
D10BA01 [21602320]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.68%
—
—
—
—
—
—
0
5
73
732
Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
7852-7 [3010130]
-1.0e+50
—
—
—
—
-1.0e+50
—
cases:0.00%
controls:0.72%
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.61%
—
—
0
6
84
828
—
—
—
—
0
5
82
814
—
Methadone [Presence] in Urine by Screen method
19550-3 [3028707]
-1.0e+50
—
—
—
—
—
-1.0e+50
cases:0.00%
controls:0.96%
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:1.09%
0
8
84
826
—
—
—
—
—
0
8
73
729
Infectious Disease
44 [38004484]
1.1e+00
—
—
—
—
—
—
cases:7.14%
controls:2.40%
—
—
—
—
—
—
—
—
—
—
—
—
6
20
78
814
—
—
—
—
—
—
Weakness/tiredness general
A04 [2002000145]
—
-1.0e+50
—
—
—
-1.0e+50
—
—
—
cases:0.00%
controls:0.72%
—
—
—
—
—
—
cases:0.00%
controls:0.61%
—
—
—
0
6
84
828
—
—
—
0
5
82
814
—
Thorax X-ray examination outside radiological department
GD1UA [2001303652]
—
-1.0e+50
—
—
—
—
—
—
—
cases:0.00%
controls:0.84%
—
—
—
—
—
—
—
—
—
—
—
0
7
84
827
—
—
—
—
—
Unspecified nonorganic psychosis
F29 [45533099]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.84%
—
—
—
—
—
—
—
—
—
—
—
—
0
7
84
827
—
—
—
—
—
—
Type 1 diabetes mellitus, Without complications
E10.9 [45581351]
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.84%
—
—
—
—
—
—
—
—
0
7
84
825
—
—
Acute renal failure, unspecified
N17.9 [45567829]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:1.09%
—
—
—
—
—
—
0
8
73
729
Streptococcus pyogenes Ag [Presence] in Throat
18481-2 [3033319]
—
-1.0e+50
—
—
—
—
—
—
—
cases:0.00%
controls:1.08%
—
—
—
—
—
—
—
—
—
—
—
0
9
84
825
—
—
—
—
—
Basocellular carcinoma of the skin on another or unspecified part of the face
C44.31 [2000500792]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.60%
—
—
—
—
—
—
—
—
—
—
—
—
0
5
84
829
—
—
—
—
—
—
Psychiatry
26 [38004469]
-2.9e-02
—
—
—
—
—
—
cases:5.95%
controls:6.12%
—
—
—
—
—
—
—
—
—
—
—
—
5
51
79
783
—
—
—
—
—
—
Pediatric Medicine
37 [38004477]
1.4e-01
4.8e-01
—
—
—
—
—
cases:9.52%
controls:8.39%
cases:7.14%
controls:4.56%
—
—
—
—
—
—
—
—
—
—
8
70
76
764
6
38
78
796
—
—
—
—
—

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
11
11
11.11
6.21
3.2
1.4
—
—
—
0
0
36
177
2.65
4.78
3.8
4.6
—
—
—
0
0
45
277
2.18
3.40
8.6
8.6
1.08
1.10
inr
0.11
39
228
51
334
2.12
3.25
2.8
3.5
6.38
6.15
ph
0.71
32
181
60
420
2.14
3.19
3.7
3.8
0.00
0.00
estimate
-0.00
11
72
5
5
10.44
3.01
1.2
1.6
0.20
8.26
u/ml
—
5
5
5
5
10.44
3.01
2.4
1.4
—
—
—
0
0
46
300
2.02
2.87
4.0
3.1
0.25
0.00
estimate
—
8
64
58
415
2.00
2.74
3.7
3.7
0.00
0.00
estimate
-0.00
11
77
58
417
1.99
2.69
3.7
3.8
0.00
0.00
estimate
—
8
77
30
173
2.07
2.57
2.2
2.7
1.87
1.12
mg/l
0.23
21
141
48
331
1.90
2.44
6.3
8.3
—
—
—
0
0
20
100
2.26
2.42
1.6
1.4
—
—
—
0
0
38
243
1.93
2.42
1.9
2.7
10.38
28.84
ng/l
2.74
20
136
51
361
1.88
2.38
2.6
2.9
—
—
estimate
—
0
0
21
109
2.19
2.33
1.2
2.2
—
—
—
0
0
6
13
4.84
2.31
1.7
1.0
—
—
—
0
0
31
189
1.95
2.25
3.3
3.2
1.02
1.02
kg/l
0.53
19
126
66
515
1.90
2.20
3.9
4.3
—
—
—
0
0
6
14
4.49
2.18
2.2
1.2
—
—
—
0
0
31
191
1.92
2.17
2.4
2.9
—
—
—
0
0
24
136
2.02
2.12
2.0
4.0
4.58
1.99
e6/l
0.57
13
65
16
77
2.29
2.11
5.4
15.4
7.40
7.42
ph
—
8
44
7
20
3.69
2.10
1.0
2.0
—
—
—
0
0
7
20
3.69
2.10
1.0
2.0
—
—
—
0
0
7
20
3.69
2.10
1.0
2.0
—
—
—
0
0
7
20
3.69
2.10
1.0
2.0
—
—
—
0
0
38
253
1.83
2.09
2.1
2.5
—
—
—
0
0
18
97
2.05
1.81
1.3
1.3
—
—
—
0
0
20
113
1.97
1.77
8.9
19.1
25.71
24.93
mmol/l
0.50
20
113
5
13
3.99
1.73
3.8
2.6
—
—
—
0
0
15
77
2.12
1.70
5.6
15.3
0.33
1.12
mmol/l
0.45
15
64
27
172
1.79
1.67
2.8
2.3
—
—
—
0
0
17
93
2.01
1.64
2.1
3.2
4.88
4.23
e9/l
0.45
17
85
61
492
1.66
1.55
8.6
8.0
0.19
0.20
e9/l
0.18
55
431
6
21
2.98
1.53
3.2
3.0
7.41
7.42
ph
—
6
21
23
144
1.79
1.50
3.2
3.9
51.94
351.63
ng/l
1.56
16
104
31
212
1.68
1.49
2.3
3.6
0.00
0.00
estimate
—
9
74
17
99
1.87
1.38
1.8
1.7
—
—
—
0
0
58
470
1.59
1.38
4.0
4.2
—
80.88
—
0
8
20
123
1.79
1.38
2.1
10.3
7.37
7.37
ph
0.16
14
80
35
252
1.61
1.37
1.5
1.5
—
—
—
0
0
8
34
2.47
1.33
2.1
6.3
—
—
—
0
0
59
483
1.57
1.32
8.3
7.7
0.03
0.04
e9/l
0.50
53
408
59
483
1.57
1.32
8.3
7.6
0.56
0.57
e9/l
0.22
53
411
16
95
1.82
1.23
2.4
10.9
23.76
23.76
mmol/l
0.00
16
95
55
451
1.51
1.16
7.9
7.5
55.59
53.91
%
0.49
55
439
31
225
1.56
1.15
3.8
3.7
0.18
0.41
e6/l
0.76
24
158
37
282
1.51
1.09
8.4
6.2
—
—
—
0
0
16
99
1.74
1.08
4.4
14.2
106.88
104.28
mmol/l
1.39
16
99
59
496
1.49
1.07
8.4
7.6
2.08
2.18
e9/l
0.27
54
435
6
28
2.22
0.93
2.2
2.7
59.90
54.31
%
—
6
28
8
44
1.89
0.88
2.1
14.6
0.76
1.63
%
—
8
44
8
45
1.85
0.87
8.5
23.1
95.64
92.64
%
—
8
45
8
45
1.85
0.87
8.5
22.9
0.65
0.66
%
—
8
45
8
46
1.81
0.85
8.5
22.5
0.99
1.60
%
—
8
46
6
33
1.87
0.80
1.2
1.3
—
—
—
0
0
33
260
1.41
0.79
3.9
3.9
14.55
21.07
e6/l
0.35
26
193
26
196
1.45
0.79
6.4
5.1
—
—
—
0
0
35
279
1.40
0.79
1.7
1.9
—
—
—
0
0
90
854
1.86
0.78
13.5
10.9
—
—
—
0
0
60
524
1.39
0.78
9.5
11.4
3.89
3.82
e9/l
0.09
54
450
5
25
2.05
0.74
1.0
1.6
—
—
—
0
0
50
427
1.36
0.73
11.6
11.2
0.00
0.00
e9/l
0.49
44
336
20
265
0.69
0.72
1.5
1.6
18.76
2.76
u/ml
—
5
69
7
42
1.72
0.70
2.0
15.3
0.54
0.68
%
—
7
42
5
27
1.90
0.69
1.2
9.0
36.90
37.03
°c
—
5
27
8
49
1.69
0.64
1.5
3.2
4.95
5.06
pmol/l
—
8
44
0
22
0.00
0.60
0.0
1.3
—
—
—
0
0
0
23
0.00
0.59
0.0
1.3
—
—
—
0
0
7
109
0.61
0.52
1.3
1.3
—
—
—
0
0
11
76
1.51
0.50
12.2
13.3
—
—
—
0
0
10
141
0.68
0.49
3.3
1.6
—
—
—
0
0
11
78
1.46
0.45
1.0
1.5
—
—
—
0
0
27
224
1.29
0.45
3.9
2.6
0.00
0.00
estimate
—
7
60
14
105
1.39
0.44
6.7
14.7
—
—
—
0
0
21
169
1.31
0.43
1.5
2.0
—
—
—
0
0
0
15
0.00
0.41
0.0
3.1
—
18.07
—
0
15
0
16
0.00
0.41
0.0
3.1
—
9.59
—
0
11
25
292
0.81
0.36
2.0
1.9
84.46
102.52
pmol/l
1.00
11
139
26
221
1.24
0.36
3.5
4.3
7.38
7.39
ph
1.12
21
155
23
269
0.81
0.33
3.0
3.7
8.15
8.13
mmol/l
0.01
23
240
18
148
1.27
0.32
4.1
2.7
553.00
530.59
mosm/kgh2o
0.16
18
127
7
52
1.37
0.32
1.1
1.1
—
—
—
0
0
38
343
1.18
0.28
3.7
2.8
—
—
—
0
0
18
212
0.81
0.27
3.9
3.5
60.13
41.36
mg/l
0.14
11
137
13
105
1.28
0.26
1.5
3.7
3.10
5.10
umol/l
2.24
13
94
8
102
0.76
0.22
4.6
1.8
—
—
—
0
0
0
10
0.00
0.21
0.0
1.0
—
101.80
—
0
10
6
52
1.16
0.19
1.7
1.7
—
—
—
0
0
7
57
1.25
0.19
6.3
3.1
—
—
—
0
0
33
306
1.12
0.16
4.8
5.1
20.37
41.29
e6/l
0.63
26
202
19
211
0.88
0.15
5.3
4.2
9.23
88.51
mg/mmol
0.47
11
134
17
151
1.15
0.14
1.2
1.3
1.17
2.76
u/ml
—
6
65
23
210
1.13
0.13
1.7
2.0
130.04
186.00
u/l
0.53
23
204
21
191
1.13
0.13
4.0
4.2
1.34
1.67
ug/l
0.61
21
170
10
86
1.18
0.11
1.5
1.6
—
—
—
0
0
15
165
0.89
0.09
3.0
1.7
—
—
—
0
0
20
191
1.06
0.03
3.5
2.1
—
—
—
0
0
10
92
1.10
0.03
1.4
3.6
1.34
1.71
%
—
10
87
17
163
1.05
0.01
1.4
1.3
20.92
27.58
iu/ml
—
5
49
10
98
1.02
0.00
1.0
1.2
—
—
—
0
0
15
152
0.98
0.00
9.9
9.0
1.32
1.24
mmol/l
0.31
15
141
25
247
1.02
0.00
1.4
1.6
2.38
2.08
g/l
0.49
17
143
17
174
0.97
0.00
4.5
2.8
5.64
4.42
e6/l
0.23
17
152
6
64
0.93
0.00
1.0
1.1
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.4
—
89.56
—
0
9
0
6
0.00
-0.00
0.0
3.5
—
7.40
—
0
6
0
5
0.00
-0.00
0.0
2.0
—
1.21
—
0
5
0
8
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
6
0.00
-0.00
0.0
25.8
—
1410.50
—
0
6
0
8
0.00
-0.00
0.0
1.5
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.8
—
1.52
—
0
5
9
95
0.94
-0.00
1.3
1.2
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
6
0.00
-0.00
0.0
24.5
—
775.17
—
0
6
0
7
0.00
-0.00
0.0
2.0
—
1.63
—
0
7
0
5
0.00
-0.00
0.0
1.8
—
6.24
—
0
5
0
6
0.00
-0.00
0.0
1.5
—
—
—
0
0
5
56
0.89
-0.00
1.2
1.4
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.7
—
5.77
—
0
9
0
7
0.00
-0.00
0.0
39.7
—
148.00
—
0
7
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
5.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
2.2
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.4
—
3.27
—
0
5
0
9
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
7
0.00
-0.00
0.0
3.4
—
137.57
—
0
7
0
9
0.00
-0.00
0.0
1.6
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
0.80
—
0
5
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
7
0.00
-0.00
0.0
3.1
—
—
—
0
0
0
6
0.00
-0.00
0.0
11.3
—
0.59
—
0
6
0
5
0.00
-0.00
0.0
1.8
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0

Mortality – FinRegistry

↥

Association

Association between endpoint Q17_CONGEN_MALFO_LUNG and mortality.

Females

No data

Males

No data

Mortality risk

Mortality risk for people of age

years, who have Q17_CONGEN_MALFO_LUNG.

N-year risk Females Males
1 No data No data
5 No data No data
10 No data No data
15 No data No data
20 No data No data

Relationships between endpoints

↥

Index endpoint: Q17_CONGEN_MALFO_LUNG – Congenital malformations of lung

GWS hits: -

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data